Trial Profile
A Randomized, Double-Blind, Multiple-Dose, Parallel Group Study to Evaluate the Potential of Withdrawal Effects Following Administration of Oxycodone/Naltrexone Capsules and Oxycodone in Methadone-Maintained Opioid-Dependent Subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Mar 2015
Price :
$35
*
At a glance
- Drugs Oxycodone/naltrexone (Primary) ; Oxycodone
- Indications Pain
- Focus Therapeutic Use
- Sponsors Elite Pharmaceuticals
- 23 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Mar 2015 New trial record